The prevalence of interstitial lung disease (ILD) across connective tissue disorders (CTDs) and its persistent standing as a leading cause of death in patients with CTDs challenge rheumatologists ...

Artificial intelligence company Brainomix has claimed FDA approval for e-Lung, which assists in the diagnosis and assessment of patients with interstitial lung diseases (ILDs) from medical images.

IMVARIA has gained 510(k) clearance from the US Food and Drug Administration (FDA) for its AI-powered healthcare tool, ScreenDx, designed to help clinicians in interstitial lung disease (ILD ...